Rapid detection of exon 2-deleted AIMP2 mutation as a potential biomarker for lung cancer by molecular beacons

Biosensors and Bioelectronics

Volumn 46, Issue , 2013, Pages 142-149

  Jo, Seong Min ^a   Kim, Youngwook ^b   Jeong, Young Su ^a   Hee Oh, Young ^a   Park, Keunchil ^b,c   Kim, Hak Sung ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Sam sung BiomedicalResearchInstitute   (South Korea)

Author keywords

AIMP2 DX2; Biomarker; Diagnosis; Lung cancer; Molecular beacon

Indexed keywords

AIMP2-DX2; FLUORESCENCE IMAGING; LUNG CANCER; MOLECULAR BEACON; MULTIFUNCTIONAL PROTEIN; OVARIAN CANCERS; RAPID DETECTION; SENSITIVE DETECTION;

BIOLOGICAL ORGANS; BIOMARKERS; DIAGNOSIS; LIPOSOMES; POLYMERASE CHAIN REACTION; TISSUE;

DISEASES;

FOLIC ACID; LIPOSOME; TUMOR MARKER;

AMINOACYL TRNA SYNTHETASE COMPLEX INTERACTING MULTIFUNCTIONAL PROTEIN 2 GENE; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DISEASE MARKER; EMBRYO; EXON; FEMALE; FLUORESCENCE IMAGING; GENE DELETION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MOLECULAR BEACON; MOLECULAR MODEL; MUTATIONAL ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; TUMOR GENE; VALIDATION PROCESS;

BASE SEQUENCE; CARRIER PROTEINS; CELL LINE, TUMOR; EXONS; FOLIC ACID; HUMANS; LIPOSOMES; LUNG; LUNG NEOPLASMS; OPTICAL IMAGING; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE DELETION;

EID: 84875684905     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2013.02.037     Document Type: Article

References (31)

1. Antony K.C., Mark A.B., Andrew T. Nucleic Acids Research 2007, 35:e105.
2. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. Proceedings of the National Academy of Science 1995, 92:7297-7301.
3. Byrne J.D., Betancourt T., Brannon-Peppas L. Advanced Drug Delivery Reviews 2008, 60:1615-1626.
4. Choi J.W., Kim D.G., Lee A.-E., Kim H.R., Lee J.Y., Kwon N.H., Shin Y.K., Hwang S.-K., Chang S.-H., Cho M.-H., Choi Y.-L., Kim J., Oh S.H., Kim B., Kim S.-Y., Jeon H.-S., Park J.Y., Kang H.P., Park B.J., Han J.M., Kim S. PLoS Genetics 2011, 7:e1001351.
5. Choi J.W., Kim D.G., Park M.C., Um J.Y., Han J.M., Park S.G., Choi E.-C., Kim S. Journal of Cell Science 2009, 122:2710-2715.
6. Choi J.W., Lee J.-W., Kim J.K., Jeon H.-K., Choi J.-J., Kim D.G., Kim B.G., Nam D.-H., Kim H.J., Yun S.H., Kim S. Journal of Molecular Cell Biology 2012, 4:164-173.
7. Gao J., Sun J., Li H., Liu W., Zhang Y., Li B., Qian W., Wang H., Chen J., Guo Y. Biomaterials 2010, 31:2655-2664.
8. Han J.M., Park B.-J., Park S.G., Oh Y.S., Choi S.J., Lee S.W., Hwang S.-K., Chang S.-H., Cho M.-H., Kim S. Proceedings of the National Academy of Science 2008, 105:11206-11211.
9. Iwan W., Sebastian C.B., Fred H., Nabil D., Angela V., Klaus A., Sucharit B. Proceedings of the National Academy of Science 2001, 98:3185-3190.
10. Kim S., You S., Hwan D. Nature Reviews Cancer 2011, 11:708-718.
11. Lee R.J., Low P.S. Biochimica et Biophysica Acta-Biomembranes 1995, 1233:134-144.
12. Li S., Gao X., Son K., Sorgi F., Hofland H., Huang L. Journal of Controlled Release 1996, 39:373-381.
13. Livesey F.J. Briefings in Functional Genomics 2003, 2:31-36.
14. Marras S.A., Tyagi S., Kramer F.R. Clinica Chimica Acta 2006, 363:48-60.
15. Marras, S.A., 2006. in: Didenko, V.V., (Ed.) Methods in Molecular Biology, Humana Press Inc., Totowa, NJ, Vol. 335, pp. 3-16.
16. Oh Y.H., Kim Y., Kim Y.P., Seo S.W., Mitsudomi T., Ahn M.J., Park K., Kim H.S. Journal of Molecular Diagnostics 2010, 12:644-652.
17. Peng X.H., Cao Z.H., Xia J.T., Carlson G.W., Lewis M.M., Wood W.C., Yang L. Cancer Research 2005, 65:1909-1917.
18. Santangelo P.J., Nix B., Tsourkas A., Bao G. Nucleic Acids Research 2004, 32:e57.
19. Saul J.M., Annapragada A., Natarajan J.V., Bellamkonda R.V. Journal of Controlled Release 2003, 92:49-67.
20. Schwarzenbach H., Hoon D.S.B., Pantel K. Nature Reviews Cancer 2011, 11:426-437.
21. Siegel R., Naishadham D., Jemal A. CA-Cancer Journal of Clinicians 2012, 62:10-29.
22. Tyagi S., Kramer F.R. Nature Biotechnology 1996, 14:303-308.
23. Varkouhi A.K., Scholte M., Storm G., Haisma H.J. Journal of Controlled Release 2011, 151:220-228.
24. Vet, J.A., Marras, S.A., 2005. in: Herdewijn, P., (Ed.) Methods in Molecular Biology, Humana Press Inc., Totowa, NJ, Vol. 288, pp. 273-289.
25. Weng, J., Zhang, Z., Sun, L., Wang, J.A., 2011. Biosensors and Bioelectronics 26, 1847-1852.
26. White A.K., VanInsberghe M., Petriv O.I., Hamidi M., Sikorski D., Marra M.A., Piret J., Aparicio S., Hansen C.L. Proceedings of the National Academy of Science 2011, 108:13999-14004.
27. Won Y.S., Lee S.W. Journal of Biotechnology 2012, 158:44-49.
28. Yang L., Cao Z., Lin Y., Wood W.C., Staley C.A. Cancer Biology and Therapy 2005, 4:561-570.
29. Yatabe Y., Hida T., Horio Y., Kosaka T., Takahashi T., Mitsudomi T. Journal of Molecular Diagnostics 2006, 8:335-341.
30. Zhang X.-B., Wang Z., Xing H., Xiang Y., Lu Y. Analytical Chemistry 2010, 82:5005-5011.
31. Zhao X., Li H., Lee R.J. Advanced Drug Delivery Reviews 2000, 41:147-162.